Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis

Nature Medicine

Volumn 5, Issue 11, 1999, Pages 1317-1321

  Heaney, Anthony P ^a   Horwitz, Gregory A ^a   Wang, Zhiyong ^a   Singson, Regina ^a   Melmed, Shlomo ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; PROLACTIN; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MUTANT; CHROMOSOMAL LOCALIZATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; HORMONAL REGULATION; HYPOPHYSIS TUMOR; IMMUNOHISTOCHEMISTRY; MALIGNANT TRANSFORMATION; NONHUMAN; ONCOGENE; PARACRINE SIGNALING; PRIORITY JOURNAL; PROLACTIN RELEASE; PROLACTINOMA; RAT; RECEPTOR INTRINSIC ACTIVITY; TUMOR GROWTH;

3T3 CELLS; ANIMALS; BASE SEQUENCE; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; DNA PRIMERS; ESTROGENS; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; MICE; NEOPLASM PROTEINS; ONCOGENE PROTEINS; PITUITARY NEOPLASMS; PROLACTINOMA; PROMOTER REGIONS (GENETICS); RATS; RATS, INBRED F344; TRANSFECTION;

EID: 0032742157     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/15275     Document Type: Article

References (22)

1. Shimon, I., Melmed, S. Genetic basis of endocrine disease: pituitary tumor pathogenesis. J. Clin. Endocrinol. Metab. 82, 1675-1681 (1997).
2. Wilson, C.B. Extensive personal experience: Surgical management of pituitary tumors. J. Clin. Endocrinol. Metab. 82, 2381-2385 (1997).
3. Gothard, L. Q., Hibbard, J.C. & Seyfred, M.A. Estrogen-mediated induction of rat prolactin gene transcription requires the formation of a chromatin loop between the distal enhancer and proximal promoter regions. Mol. Endocrinol. 10, 185-195 (1996).
4. Scully, K.M. et al. Role of estrogen receptor-α in the anterior pituitary gland. Mol. Endocrinol. 11, 674-681 (1997).
5. Baird, A. et al. A nonmitogenic pituitary function of fibroblast growth factor: regulation of thyrotrophin and prolactin secretion. Proc. Natl. Acad. Sci. USA 82, 5545-5549 (1985).
6. Smallwood, P. et al. Fibroblast growth factor (FCF) homologous factors: new members of the FCF family implicated in nervous system development. Proc. Natl. Acad. Sci. USA 93, 9850-9857 (1996).
7. Li, Y. et al. Identification and characterization of high molecular weight forms of basic fibroblast growth factor in human pituitary adenomas. J. Clin. Endocrinol. Metab. 75, 1436-1441 (1992).
8. Zimmering, M.B. et al. Increased basic fibroblast growth factor in plasma from multiple endocrine neoplasia type-1: relation to pituitary tumor. J. Clin. Endocrinol. Metab. 76, 1182-1187 (1993).
9. Pei, L. & Melmed S. Isolation and characterisation of a pituitary tumor-transforming gene (PTTG). Mol. Endocrinol. 11, 433-441 (1997).
10. Zhang, X. et al. Structure, expression and function of human pituitary transforming gene (PTTG). Mol. Endocrinol. 13, 156-166 (1999).
11. Zou, H., McGarry, T.J., Bernal, T. & Kirschner, M.W. Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis. Science 285, 418-422 (1999).
12. Prezant, T.P., Kadioglu, P., Melmed, S. An intronless homolog of human protooncogene hPTTG is expressed in pituitary tumors:evidence for hPTTG family. J. Clin. Endocrinol. Metab.84, 1149-1152 (1999).
13. Zhang, X. et al. Pituitary tumor transforming gene expression in human pituitary adenomas. J. Clin. Endocrinol. Metab.84, 761-767 (1999)
14. Seghezzi, G. et al. Fibroblast growth factor-2 (FGF-2) induces vascular endothelial factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis. J. Cell. Biol. 141, 1659-1673 (1998).
15. Shupnik, M.A. & Rosenzweig, B. Identification of an estrogen-responsive element in the rat LHβ gene. J. Biol. Chem. 26, 17084-17091 (1991)
16. Hanahan, D. & Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353-364 (1996)
17. Weiner, R. I., Elias, K.A. & Monnet, F. in Prolactin. Basic and Clinical Correlates (eds. Macleod, R.M., Thorner, M.O. & Scapagnini, U.) 641-653 (Liviana Press, Padova, Italy, 1995).
18. Kovacs, K., Ryan, N., Horvath, E., Ezrin G. & Penz, G. Prolactin cell adenomas of the human pituitary. Morphological features of prolactin cells in the nontumorous portions of the anterior lobe. Horm. Metab. Res. 10, 409-412 (1978).
19. Schecther, J., Goldsmith, P., Wilson, C. & Weiner, R. Morphological evidence for the presence of arteries in human prolactinomas. J. Clin. Endocrinol. Metab. 67, 713-719 (1988).
20. Serri, O., Noiseux, D., Robert, F. & Hardy, J. Lactotroph hyperplasia in an estrogen treated male-to-female transsexual patient. J. Clin. Endocrinol. Metab. 81, 3177-3179 (1996).
21. Stefaneanu, L. et al. In situ hybridisation study of estrogen receptor messenger ribonucleic acid in human adenohypophysial cells and pituitary adenomas. J. Clin. Endocrinol. Metab. 78, 83-88 (1994).
22. Wiklund, J., Wertz, N. & Gorski, J. A comparison of estrogen effects on uterine and pituitary growth and prolactin synthesis in F344 and Holtzman rats. Endocrinology 109, 1700-1707 (1981).